BioVentrix is a San Ramon, California-based medical device company that focuses on improving and expanding the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
15
Funding Rounds
$114.9m
Money raised